| Literature DB >> 23993949 |
Abstract
Opioids are among the most frequently used analgesics for treatment of severe pain. However, certain of their side-effects, particularly ventilatory disturbances, often restrict their use. Separation of analgesia from respiratory depression has long been a goal in the basic research and therapeutic use of opioids. This report briefly describes opioid-induced respiratory depression and possible pharmacological strategies to counteract this without affecting analgesia.Entities:
Keywords: Cholinesterase inhibitor; Methylxanthine; Opioid; Phosphodiesterase inhibitor; Respiratory depression; Serotonergic agonist
Mesh:
Substances:
Year: 2013 PMID: 23993949 DOI: 10.1016/j.ejphar.2013.08.007
Source DB: PubMed Journal: Eur J Pharmacol ISSN: 0014-2999 Impact factor: 4.432